Reaction

Oligodendroglioma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 120 reports · 2 co-occurring drugs

As of the last recalculation, Oligodendroglioma appears in 120 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is TEMOZOLOMIDE (PRR 162.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Temozolomide17162.9163.0
Olaparib761.661.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.